Physician profile
Jerry Aravamudhan Krishnan
NPI 1205883444
$27,030.50
in general payments reported to CMS, 2019-2025
6 companies · $13K in 2025
The $13K reported for 2025 was more than what 94% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,225 · 2023: $5,500 · 2024: $3,834 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Honoraria: $5,525 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,600 · Food and Beverage: $910 · Travel and Lodging: $901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,870.00 |
| Honoraria | $5,525.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,600.00 |
| Food and Beverage | $909.68 |
| Travel and Lodging | $900.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $9,721.02 | 2025 | Inogen Rove 6 |
| Astrazeneca Ab | $5,500.00 | 2023 | |
| Glaxosmithkline, LLC. | $4,225.00 | 2021 | |
| Genentech USA, INC. | $3,834.48 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $3,750.00 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Krishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.